Advertisement
Screener

BIO KEY INTERNATIONAL INC (BKYI) Deferred Foreign Income Tax Expense (Benefit)

1.8 / 5 stars · 29/80 Roast Me

BIO KEY INTERNATIONAL INC Deferred Foreign Income Tax Expense (Benefit)

BIO KEY INTERNATIONAL INC (BKYI) reported Deferred Foreign Income Tax Expense (Benefit) of -$175.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-05.

Discontinued › Expense Statement › Income Tax

us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2024-06-05

  • BIO KEY INTERNATIONAL INC deferred foreign income tax expense (benefit) for fiscal 2023 was -$175.00K.
  • BIO KEY INTERNATIONAL INC deferred foreign income tax expense (benefit) for fiscal 2022 was -$20.43K.
  • BIO KEY INTERNATIONAL INC deferred foreign income tax expense (benefit) for fiscal 2021 was $0.00.
Period endDeferred Foreign Income Tax Expense (Benefit) 12 monthDeferred Foreign Income Tax Expense (Benefit) 12 month as first filed
2023-12-31-$175.00K
10-K · filed 2024-06-05
2022-12-31-$20.43K
10-K · filed 2024-06-05
-$20.00K
10-K · filed 2023-06-01
2021-12-31$0.00
10-K · filed 2023-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Iveda Solutions, Inc. (IVDA)United States$0.004B
CYABRA, INC. (CYAB)$0.004B
Zedge, Inc. (ZDGE)United States$0.002B0.43
My Size, Inc. (MYSZ)$0.001B
GAXOS.AI INC. (GXAI)United States$0.006B-3.26
Amesite Inc. (AMST)United States$0.007B-2.79
authID Inc. (AUID)United States$0.007B
zSpace, Inc. (ZSPC)United States$0.009B
FingerMotion, Inc. (FNGR)Singapore$0.009B-6.67
AppTech Payments Corp. (APCX)United States$0.010B